Somewhat Favorable News Coverage Somewhat Unlikely to Impact Motus GI (MOTS) Stock Price

Share on StockTwits

Press coverage about Motus GI (NASDAQ:MOTS) has trended somewhat positive on Sunday, according to Accern. Accern rates the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Motus GI earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave news stories about the company an impact score of 48.6109500494805 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Shares of Motus GI traded up $0.24, reaching $5.99, during midday trading on Friday, according to Marketbeat. The company’s stock had a trading volume of 18,911 shares, compared to its average volume of 51,908. Motus GI has a fifty-two week low of $3.75 and a fifty-two week high of $10.66. The company has a market capitalization of $89.96 million and a PE ratio of -4.68.

Motus GI (NASDAQ:MOTS) last posted its quarterly earnings data on Tuesday, May 15th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.24) by ($0.09). The firm had revenue of $0.01 million for the quarter. sell-side analysts predict that Motus GI will post -1.09 earnings per share for the current fiscal year.

A number of analysts have recently issued reports on the stock. Oppenheimer set a $10.00 price objective on shares of Motus GI and gave the company a “buy” rating in a report on Friday, July 13th. Zacks Investment Research downgraded shares of Motus GI from a “hold” rating to a “sell” rating in a report on Wednesday, July 18th. ValuEngine upgraded shares of Motus GI from a “hold” rating to a “buy” rating in a report on Wednesday, July 4th. Finally, EuroPacific Canada assumed coverage on shares of Motus GI in a report on Thursday, May 31st. They issued a “buy” rating and a $12.00 price objective on the stock. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $9.67.

In other Motus GI news, Director Gary E. Jacobs acquired 5,000 shares of the stock in a transaction dated Friday, May 18th. The shares were bought at an average cost of $5.24 per share, for a total transaction of $26,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

About Motus GI

Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Recommended Story: Average Daily Trade Volume – ADTV

Insider Buying and Selling by Quarter for Motus GI (NASDAQ:MOTS)

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Brokerages Set The Western Union Company  Price Target at $18.25
Brokerages Set The Western Union Company Price Target at $18.25
CaliphCoin Tops One Day Trading Volume of $0.00
CaliphCoin Tops One Day Trading Volume of $0.00
Analysts Anticipate Acadia Healthcare Company Inc  Will Post Earnings of $0.65 Per Share
Analysts Anticipate Acadia Healthcare Company Inc Will Post Earnings of $0.65 Per Share
Somewhat Negative News Coverage Somewhat Unlikely to Impact BIO-key International  Stock Price
Somewhat Negative News Coverage Somewhat Unlikely to Impact BIO-key International Stock Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Burcon Nutrascience  Share Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Burcon Nutrascience Share Price
Zacks: Analysts Anticipate Pool Co.  to Announce $1.57 EPS
Zacks: Analysts Anticipate Pool Co. to Announce $1.57 EPS


Leave a Reply

© 2006-2018 Ticker Report. Google+.